PRAC updates on the risks of serious vascular occlusive events associated with cancer medicine Iclusig

View source ↗

Summary

PRAC provides updates on the risk of serious vascular occlusive events with cancer medicine Iclusig (ponatinib), highlighting safety concerns and monitoring rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia
• Leukemia

Drugs mentioned

• Iclusig (ponatinib)